136 related articles for article (PubMed ID: 11448089)
1. Urinary retention caused after fluoxetine-risperidone combination.
Bozikas V; Petrikis P; Karavatos A
J Psychopharmacol; 2001 Jun; 15(2):142-3. PubMed ID: 11448089
[TBL] [Abstract][Full Text] [Related]
2. Urinary retention with fluoxetine-haloperidol combination in a young patient.
Benazzi F
Can J Psychiatry; 1996 Nov; 41(9):606-7. PubMed ID: 8946091
[No Abstract] [Full Text] [Related]
3. Extrapyramidal reactions from concurrent SSRI and atypical antipsychotic use.
Caley CF
Can J Psychiatry; 1998 Apr; 43(3):307-8. PubMed ID: 9561323
[No Abstract] [Full Text] [Related]
4. Re: Extrapyramidal side effects with low-dose risperidone.
Pies R
Can J Psychiatry; 1997 Oct; 42(8):881. PubMed ID: 9356779
[No Abstract] [Full Text] [Related]
5. The effect of fluoxetine on the pharmacokinetics and safety of risperidone in psychotic patients.
Bondolfi G; Eap CB; Bertschy G; Zullino D; Vermeulen A; Baumann P
Pharmacopsychiatry; 2002 Mar; 35(2):50-6. PubMed ID: 11985287
[TBL] [Abstract][Full Text] [Related]
6. Gynecomastia with risperidone-fluoxetine combination.
Benazzi F
Pharmacopsychiatry; 1999 Jan; 32(1):41. PubMed ID: 10071182
[TBL] [Abstract][Full Text] [Related]
7. [Severe tardive dyskinesia during treatment with risperidone and fluoxetine].
Dubbelman YD; Thung FH; Heeringa M
Ned Tijdschr Geneeskd; 1998 Jun; 142(26):1508-11. PubMed ID: 9752071
[TBL] [Abstract][Full Text] [Related]
8. Risperidone-induced extrapyramidal side effects: is the need for anticholinergics the consequence of high plasma concentrations?
Schoretsanitis G; Haen E; Hiemke C; Gründer G; Stegmann B; Schruers KR; Veselinovic T; Lammertz SE; Paulzen M
Int Clin Psychopharmacol; 2016 Sep; 31(5):259-64. PubMed ID: 27167902
[TBL] [Abstract][Full Text] [Related]
9. Behavioural effects of chronic haloperidol and risperidone treatment in rats.
Karl T; Duffy L; O'brien E; Matsumoto I; Dedova I
Behav Brain Res; 2006 Aug; 171(2):286-94. PubMed ID: 16697060
[TBL] [Abstract][Full Text] [Related]
10. Rabbit syndrome secondary to risperidone.
Hoy JS; Alexander B
Pharmacotherapy; 2002 Apr; 22(4):513-5. PubMed ID: 11939686
[TBL] [Abstract][Full Text] [Related]
11. [Urinary retention with risperidone].
Siepmann M; Olbrich H
Psychiatr Prax; 1997 Jul; 24(4):209. PubMed ID: 9340666
[No Abstract] [Full Text] [Related]
12. Prediction and assessment of extrapyramidal side effects induced by risperidone based on dopamine D(2) receptor occupancy.
Yamada Y; Ohno Y; Nakashima Y; Fukuda M; Takayanagi R; Sato H; Tsuchiya F; Sawada Y; Iga T
Synapse; 2002 Oct; 46(1):32-7. PubMed ID: 12211096
[TBL] [Abstract][Full Text] [Related]
13. Urinary retention with venlafaxine-haloperidol combination.
Benazzi F
Pharmacopsychiatry; 1997 Jan; 30(1):27. PubMed ID: 9065967
[No Abstract] [Full Text] [Related]
14. Extrapyramidal side-effect due to drug combination of risperidone and donepezil.
Liu HC; Lin SK; Sung SM
Psychiatry Clin Neurosci; 2002 Aug; 56(4):479. PubMed ID: 12109969
[No Abstract] [Full Text] [Related]
15. Extrapyramidal side effects in a patient treated with risperidone plus donepezil.
Magnuson TM; Keller BK; Burke WJ
Am J Psychiatry; 1998 Oct; 155(10):1458-9. PubMed ID: 9766783
[No Abstract] [Full Text] [Related]
16. Risperidone treatment of behavioral disturbances in outpatients with dementia.
Irizarry MC; Ghaemi SN; Lee-Cherry ER; Gomez-Isla T; Binetti G; Hyman BT; Growdon JH
J Neuropsychiatry Clin Neurosci; 1999; 11(3):336-42. PubMed ID: 10440009
[TBL] [Abstract][Full Text] [Related]
17. Extrapyramidal Symptoms as a Result of Risperidone Discontinuation During Combination Therapy with Methylphenidate in a Pediatric Patient.
Pérez CA; Garcia SS; Yu RD
J Child Adolesc Psychopharmacol; 2016 Mar; 26(2):182. PubMed ID: 26871198
[No Abstract] [Full Text] [Related]
18. A qualitative assessment of the neurological safety of antipsychotic drugs; an analysis of a risperidone database.
Fleischhacker WW; Lemmens P; van Baelen B
Pharmacopsychiatry; 2001 May; 34(3):104-10. PubMed ID: 11434401
[TBL] [Abstract][Full Text] [Related]
19. Risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine.
Schillevoort I; de Boer A; Herings RM; Roos RA; Jansen PA; Leufkens HG
Ann Pharmacother; 2001 Dec; 35(12):1517-22. PubMed ID: 11793611
[TBL] [Abstract][Full Text] [Related]
20. Extrapyramidal symptoms resulting from risperidone use in a four year old child: A case report.
Elahi E; Zia U; Bhutta OA; Andleeb S
J Pak Med Assoc; 2018 Nov; 68(11):1719-1720. PubMed ID: 30410159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
